EUVIMEDEUVIMED entdecken
Crossref

A randomised controlled study of Bronchoscopic Lung Volume Reduction with endobronchial valves for patients with Heterogeneous emphysema and Intact interlobar Fissures: the BeLieVeR-HIFi study

Zaid Zoumot, Claire Davey, Simon Jordan, William H McNulty, Denis H Carr, Matthew D Hind, David M Hansell, Michael B Rubens, Winston Banya, Michael I Polkey, Pallav L Shah, Nicholas S Hopkinson

Efficacy and Mechanism Evaluation · 2015

DOI: 10.3310/eme02050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Efficacy and Mechanism Evaluation, 2015. Verfasst von Zaid Zoumot und 11 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Efficacy and Mechanism Evaluation programme, Medical Research Council.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite optimal therapy many patients with emphysema remain significantly breathless and limited. Bronchoscopic lung volume reduction (BLVR), using valves placed to allow air to leave but not enter the worst-affected areas of the lung, has been proposed as a way to improve lung function in these patients, but response is variable because interlobar collateral ventilation prevents the devices from working. Based on retrospective analysis of clinical trials, patients with heterogeneous emphysema and intact interlobar fissures are most likely to benefit.

Objectives

To establish whether or not it is possible to identify patients prospectively who will reliably benefit from endobronchial valve placement.

Design

Prospective, randomised, parallel-group, double-blind, sham-controlled trial.

Setting

The study was performed at a single specialist centre.

Participants

Adult patients with heterogeneous emphysema and a target lobe with intact interlobar fissures were eligible if they had significant gas trapping (total lung capacity > 100% predicted, residual volume > 150% predicted), breathlessness [Medical Research Council (MRC) dyspnoea score of ≥ 3] and exercise limitation (6-minute walk distance of < 450 m). Participants were on optimised pharmacotherapy and were non-smokers.

Interventions

Study participants were randomised to either unilateral lobar endobronchial valve placement aiming to achieve lobar atelectasis or bronchoscopy and ‘sham’ valve placement. Main outcome measures The primary end point was improvement in forced expiratory volume in 1 second (FEV 1 ) in the treatment arm compared with the control arm measured 90 days post procedure. Secondary end points were change in lung volumes, gas transfer, exercise capacity (both walking and endurance cycle ergometry) and health-related quality of life.

Results

In total, 50 patients were recruited, 25 to each arm; 62% were male and mean (standard deviation) FEV 1 % predicted was 31.7% (10.2%). The primary end point of the study was met as FEV 1 increased by 24.8% [95% confidence interval (CI) 8.0% to 41.5%] in the treatment arm and by 3.9% (95% CI 0.7% to 7.1%) in the control arm [between-group difference 20.9% (95% CI 4.3% to 37.5%); p = 0.033]. There were both statistically and clinically significant improvements in lung volumes and carbon monoxide gas transfer as well as endurance time and dynamic hyperinflation during cycle ergometry. Two deaths occurred in the treatment arm and one control patient was unable to attend for follow-up assessment because of a prolonged pneumothorax. Two pneumothoraces occurred in the treatment arm.

Conclusions

With appropriate selection of patients through a multidisciplinary team it is possible to produce a significant improvement in lung function through lobar occlusion with endobronchial valves in heterogeneous emphysema. Prospective trials are needed to compare the effect of BLVR with surgical approaches in terms of magnitude and duration of benefit.

Trial registration

Current Controlled Trials ISRCTN04761234. Funding This project was funded by the Efficacy and Mechanism Evaluation (EME) programme, a MRC and NIHR partnership.

Förderung

  • Efficacy and Mechanism Evaluation programme
  • Medical Research Council

Zitieren

APA

Zoumot, Z., Davey, C., Jordan, S., McNulty, W. H., Carr, D. H., Hind, M. D., Hansell, D. M., Rubens, M. B., Banya, W., Polkey, M. I., Shah, P. L., & Hopkinson, N. S. (2015). A randomised controlled study of Bronchoscopic Lung Volume Reduction with endobronchial valves for patients with Heterogeneous emphysema and Intact interlobar Fissures: the BeLieVeR-HIFi study. Efficacy and Mechanism Evaluation. https://doi.org/10.3310/eme02050

Vancouver

Zoumot Z, Davey C, Jordan S, McNulty WH, Carr DH, Hind MD, et al. A randomised controlled study of Bronchoscopic Lung Volume Reduction with endobronchial valves for patients with Heterogeneous emphysema and Intact interlobar Fissures: the BeLieVeR-HIFi study. Efficacy and Mechanism Evaluation. 2015. doi:10.3310/eme02050

BibTeX
@article{Zoumot2015,
  author = {Zoumot, Zaid and Davey, Claire and Jordan, Simon and McNulty, William H and Carr, Denis H and Hind, Matthew D and Hansell, David M and Rubens, Michael B and Banya, Winston and Polkey, Michael I and Shah, Pallav L and Hopkinson, Nicholas S},
  title = {A randomised controlled study of Bronchoscopic Lung Volume Reduction with endobronchial valves for patients with Heterogeneous emphysema and Intact interlobar Fissures: the BeLieVeR-HIFi study},
  journal = {Efficacy and Mechanism Evaluation},
  year = {2015},
  doi = {10.3310/eme02050}
}
Kostenlos starten →